Cited by 375Immune cells in cancerAdenosine and Purinergic SignalingAngiogenesis and VEGF in Cancer

The Adenosine-Dependent Angiogenic Switch of Macrophages to an M2-Like Phenotype is Independent of Interleukin-4 Receptor Alpha (IL-4Rα) Signaling

Open access
Ferrante, Christopher James, Pinhal-Enfield, Grace, Elson, Genie, Cronstein, Bruce Neil, Hasko, Gyorgy, Outram, Shalini, Leibovich, Samuel Joseph·2013·Inflammation

Abstract

Murine macrophages are activated by interferon-γ (IFN-γ) and/or Toll-like receptor (TLR) agonists such as bacterial endotoxin (lipopolysaccharide [LPS]) to express an inflammatory (M1) phenotype characterized by the expression of nitric oxide synthase-2 (iNOS) and inflammatory cytokines such as tumor necrosis factor-α (TNF-α) and interleukin (IL)-12. In contrast, Th2 cytokines IL-4 and IL-13 activate macrophages by inducing the expression of arginase-1 and the anti-inflammatory cytokine IL-10 in an IL-4 receptor-α (IL-4Rα)-dependent manner. Macrophages activated in this way are designated as "alternatively activated" (M2a) macrophages. We have shown previously that adenosine A2A receptor (A(2A)R) agonists act synergistically with TLR2, TLR4, TLR7, and TLR9 agonists to switch macrophages into an "M2-like" phenotype that we have termed "M2d." Adenosine signaling suppresses the TLR-dependent expression of TNF-α, IL-12, IFN-γ, and several other inflammatory cytokines by macrophages and induces the expression of vascular endothelial growth factor (VEGF) and IL-10. We show here using mice lacking a functional IL-4Rα gene (IL-4Rα(-/-) mice) that this adenosine-mediated switch does not require IL-4Rα-dependent signaling. M2d macrophages express high levels of VEGF, IL-10, and iNOS, low levels of TNF-α and IL-12, and mildly elevated levels of arginase-1. In contrast, M2d macrophages do not express Ym1, Fizz1 (RELM-α), or CD206 at levels greater than those induced by LPS, and dectin-1 expression is suppressed. The use of these markers in vivo to identify "M2" macrophages thus provides an incomplete picture of macrophage functional status and should be viewed with caution.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s10753-013-9621-3

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Multiple pathways induce M2 and M2-like macrophages, including IL-4/IL-13-dependent signaling, TLR and IL-1R signaling with adenosine A(2A)R, CCL18, and CX3CL1.

    “Recent studies suggest multiple pathways by which macrophages are induced to develop into M2 and M2-like macrophages. One pathway occurs through an IL-4/IL-13–dependent signaling cascade,95 a second is mediated through TLR and IL-1R signaling and adenosine-sensing receptor A(2A)R,56,95,96 a third is mediated by CCL18,97 and a fourth involves CX3CL1 (fractalkine).57”

    From The Innate Immune System in Acute and Chronic Wounds (2016) · cites this paper as [95]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. [29]Ramanathan M 2009 Differential regulation of HIF-1alpha isoforms in murine macrophages by TLR4 and adenosine A(2A) receptor agonists J Leukoc Biol 86 681 689 19477908 PMC2796622
  2. [34]Ramanathan M 2007 Synergistic up-regulation of vascular endothelial growth factor (VEGF) expression in macrophages by adenosine A2A receptor agonists and endotoxin involves transcriptional regulation via the hypoxia response element in the VEGF promoter Mol Biol Cell 18 14 23 17065555 PMC1751314

Cited by

Sorted by citations

Authors
Ferrante, C. J., Pinhal-Enfield, G., Elson, G., Cronstein, B. N., Hasko, G., Outram, S., & Leibovich, S. J.
Affiliations
  • Rutgers New Jersey Medical School (US)
  • New York University (US)
Corresponding author
Leibovich, Samuel Joseph
Venue
Inflammation
Published
2013-03-17
Volume
36
Issue
4
Pages
921-931
ISSN
  • 0360-3997 (ISSN-L)
  • 1573-2576
OpenAlex
W1998752508
Cited by
375
References
41
Citations by year
2026: 20 · 2025: 42 · 2024: 43 · 2023: 51 · 2022: 42 · 2021: 37 · 2020: 32 · 2019: 25 · 2018: 25 · 2017: 17 · 2016: 18 · 2015: 11 · 2014: 11 · 2013: 1
FWCI
7.55
Type
journal article
Language
en
Open access
Locations
  • Inflammation (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institute of General Medical Sciences (R01GM068636, R01GM066189)
  • National Institute of Allergy and Infectious Diseases (R21AI097731)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Adenosine and Purinergic Signaling
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
Keywords
adenosine, adenosine A2A receptor, macrophage polarization, M2 macrophages, IL-4 receptor alpha, Toll-like receptor signaling, vascular endothelial growth factor, IL-10, arginase-1, inducible nitric oxide synthase, Th2 cytokines, macrophage markers, Dectin-1, lipopolysaccharide
MeSH terms
Mannose Receptor, Dectin-1, Adenosine, Animals, Arginase, beta-N-Acetylhexosaminidases, Cell Differentiation, Cells, Cultured, Macrophage Activation, Macrophages, Male, Mice, Inbred BALB C, Mice, Transgenic, Receptors, Cell Surface, Tumor Necrosis Factor-alpha, Signal Transduction, Interleukin-10, Interleukin-12, Neovascularization, Physiologic, Intercellular Signaling Peptides and Proteins, Lectins, Lectins, C-Type, Mannose-Binding Lectins, Vascular Endothelial Growth Factor A, Receptor, Adenosine A2A, Mice, Nitric Oxide Synthase Type II, Interleukin-4 Receptor alpha Subunit, Purinergic P1 Receptor Agonists

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review